EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-146a-Enriched Extracellular Vesicles Attenuate Neuroinflammation and Promote Recovery After Ischemic Stroke

Nana Hao, FuHua Gong

Iranian Journal of Pharmaceutical Research · 15.04.2026 · 25 (1)

DOI: 10.5812/ijpr-167245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 15.04.2026. Verfasst von Nana Hao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xi'an Daxing Hospital, Xi'an, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ischemic stroke triggers a strong neuroinflammatory response involving cytokines, which are fundamentally involved in tissue damage and repair.

Objectives

The present study was designed to investigate the therapeutic potential of miR-146a-enriched extracellular vesicles derived from bone marrow mesenchymal stem cells (BMSC-EVs) in a rat model of middle cerebral artery occlusion (MCAO). Methods: miR-146a was transfected into BMSCs using Lipofectamine 3000. Extracellular vesicles (EVs) were isolated from transfected BMSCs using ultracentrifugation. Thirty rats were randomly assigned to three groups (n = 10 per group): (1) Control (received FBS), (2) miR-control EVs (miR-NC), and (3) miR-146a-enriched EVs, administered intravenously post-ischemia. Neurological deficits were evaluated with the Bederson score, and cytokine levels, including tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), interleukin (IL)-6, IL-10, as well as transforming growth factor β (TGF-β), were measured in splenocyte culture and brain tissues using enzyme-linked immunoassay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR), respectively. The expression of Interleukin-1 Receptor-Associated Kinase 1 (IRAK1), Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6), and nuclear factor kappa B (NF-κB) was also measured using RT-PCR.

Results

Results showed that EVs enriched in miR-146a significantly decreased pro-inflammatory cytokines, TNF-α, IFN-γ, and IL-6, and increased anti-inflammatory markers, IL-10 and TGF-β, when compared with miR-control EVs and FBS-treated groups. miR-146a-EV-treated rats also displayed better Bederson scores, which reflected better neurological recovery. Results also demonstrated that miR-146a-enriched EVs downregulated IRAK1, TRAF6, and NF-κB signaling in ischemic brain tissue.

Conclusions

These results indicate that miR-146a overexpression in BMSC-EVs can significantly inhibit neuroinflammation and promote functional improvement in ischemic stroke models, supporting its targeted therapeutic potential.

Schlagwörter

Stichwörter der Autor:innen

Bederson ScaleCytokinesExtracellular VesiclesIschemic StrokeNeuroinflammationRT-PCRmiR-146a

Autor:innen und Institutionen

  • Department of Neurology, Xi'an Daxing Hospital, Xi'an, China.
  • Department of Neurology, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, China.

Zitieren

APA

Hao, N., & Gong, F. (2026). miR-146a-Enriched Extracellular Vesicles Attenuate Neuroinflammation and Promote Recovery After Ischemic Stroke. Iranian Journal of Pharmaceutical Research, 25(1). https://doi.org/10.5812/ijpr-167245

Vancouver

Hao N, Gong F. miR-146a-Enriched Extracellular Vesicles Attenuate Neuroinflammation and Promote Recovery After Ischemic Stroke. Iranian Journal of Pharmaceutical Research. 2026;25(1). doi:10.5812/ijpr-167245

BibTeX
@article{Hao2026,
  author = {Hao, Nana and Gong, FuHua},
  title = {miR-146a-Enriched Extracellular Vesicles Attenuate Neuroinflammation and Promote Recovery After Ischemic Stroke},
  journal = {Iranian Journal of Pharmaceutical Research},
  year = {2026},
  volume = {25},
  number = {1},
  doi = {10.5812/ijpr-167245}
}
Kostenlos starten →